|
시장보고서
상품코드
1762357
세계의 제제 개발 아웃소싱 시장, 규모, 점유율, 산업 분석 보고서 : 제제별, 서비스별, 치료 분야별, 최종 용도별, 지역별, 예측(2025-2034년)Formulation Development Outsourcing Market Size, Share, & Industry Analysis Report: By Formulation, By Service (Preformulation and Formulation Development), By Therapeutic Area, By End Use, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 제제 개발 아웃소싱 시장 규모는 2034년까지 835억 5,000만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 향후 시장 성장에 대한 분석을 제공합니다.
제제 개발 아웃소싱 시장에는 전임상 및 임상 단계의 제제 활동을 전문 CDMO(Contract Development and Manufacturing Organization) 또는 CRO(Contract Research Organization)에 아웃소싱하는 것이 포함됩니다. 이러한 서비스는 특히 복잡하고 난용성 화합물의 경우, 제약 및 바이오 제약 회사가 유효성분(API)의 전달, 안정성 및 생체 이용률을 최적화할 수 있도록 지원합니다. 이 시장은 의약품 파이프라인에서 분자의 복잡성 증가, 특수 전달 시스템에 대한 수요 증가, 비용 제약 하에서 개발 기간 단축의 필요성 등으로 인해 지속적으로 성장하고 있습니다. 아웃소싱은 나노 제형, 서방형 플랫폼, 용해도 향상 기술 등 자체적으로 유지하기에는 비용이 많이 드는 고급 기능을 이용할 수 있도록 하기 위해 필수적인 요소로 자리 잡았습니다. 제약 산업을 형성하는 중요한 트렌드는 제제 개발을 신약 개발에서 상업화에 이르는 광범위한 엔드 투 엔드 서비스 모델에 통합하는 것입니다. 또한, 예측 모델링, 하이스루풋 스크리닝, 데이터 기반 제제 분석의 도입은 제제 결정 방식을 변화시키고 실패율과 사이클 타임을 감소시키고 있습니다.
다품종 소량 생산 및 고도로 맞춤화된 제형에는 민첩하고 기술력 있는 아웃소싱 파트너가 필요합니다. 규제 당국의 감시가 강화됨에 따라 공급업체는 강력한 QbD 및 위험 기반 접근법을 채택해야 하며, 그 전략적 가치는 더욱 커지고 있습니다. 디지털화, 모듈화된 서비스 제공, 실시간 배치 모니터링에 대한 중요성이 높아짐에 따라 고객-공급자 관계를 재구성하고 성능 및 컴플라이언스 벤치마킹을 재정의할 것으로 예측됩니다. 시장의 진화는 과학적 혁신과 점점 더 복잡해지는 치료 및 규제 환경에서의 업무 유연성에 대한 전략적 요구가 원동력이 되고 있습니다.
제제 개발 아웃소싱 시장 보고서 하이라이트
치료 분야별로 보면, 2024년에는 정밀 종양 치료제에 대한 수요 급증과 임상 파이프라인의 빠른 확장 속도로 인해 종양 분야가 가장 큰 점유율을 차지했습니다.
최종 용도별로는 정부 및 학술 기관 분야가 중개 연구 및 초기 신약 개발에서의 역할 확대로 인해 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예측됩니다.
2024년에는 아시아태평양이 바이오 의약품의 기술 혁신과 제네릭 의약품의 급격한 확대로 인해 가장 큰 점유율을 차지했습니다.
북미 제제 개발 아웃소싱 시장은 바이오 벤처 자본의 급증에 힘입어 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예측됩니다.
세계 주요 시장 기업으로는 Catalent, Charles River Laboratories International, Element, Eurofins Scientific, Intertek Group, Labcorp, Lonza, Recipharma, SGS S.A., Thermo Fisher Scientific, Thermo Fisher Scientific 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 제제 개발 아웃소싱 시장 인사이트
- 시장 현황
- 제제 개발 아웃소싱 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 제제 개발 아웃소싱 시장 강력함 평가 동향
- 밸류체인 분석
제5장 제제 개발 아웃소싱 시장 : 제제별
- 주요 조사 결과
- 서론
- 경구
- 주사
- 외용
- 기타
제6장 제제 개발 아웃소싱 시장 : 서비스별
- 주요 조사 결과
- 서론
- 처방전
- 처방 개발
제7장 제제 개발 아웃소싱 시장 : 치료 분야별
- 주요 조사 결과
- 서론
- 종양학
- 감염증
- 신경학
- 혈액학
- 호흡기
- 심혈관계
- 피부과
- 기타
제8장 제제 개발 아웃소싱 시장 : 최종 용도별
- 주요 조사 결과
- 서론
- 제약회사 및 바이오의약품 기업
- 정부기관 및 학술기관
- 기타
제9장 제제 개발 아웃소싱 시장 : 지역별
- 주요 조사 결과
- 서론
- 제제 개발 아웃소싱 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 배합별, 2020-2034년
- 북미 : 서비스별, 2020-2034년
- 북미 : 최종 용도별, 2020-2034년
- 북미 : 치료 분야별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 처방별, 2020-2034년
- 유럽 : 서비스별, 2020-2034년
- 유럽 : 최종 용도별, 2020-2034년
- 유럽 : 치료 분야별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제제별, 2020-2034년
- 아시아태평양 : 서비스별, 2020-2034년
- 아시아태평양 : 최종 용도별, 2020-2034년
- 아시아태평양 : 치료 분야별, 2020년-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제제별, 2020-2034년
- 중동 및 아프리카 : 서비스별, 2020-2034년
- 중동 및 아프리카 : 최종 용도별, 2020-2034년
- 중동 및 아프리카 : 치료 분야별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제제별, 2020-2034년
- 라틴아메리카 : 서비스별, 2020-2034년
- 라틴아메리카 : 최종 용도별, 2020-2034년
- 라틴아메리카 : 치료 분야별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 개요
- Catalent Inc.
- Charles River Laboratories International, Inc.
- Element
- Eurofins Scientific SE
- Intertek Group plc
- Labcorp
- Lonza
- Recipharm
- SGS S.A.
- Thermo Fisher Scientific, Inc.
The formulation development outsourcing market size is expected to reach USD 83.55 billion by 2034, according to a new study by Polaris Market Research. The report "Formulation Development Outsourcing Market Size, Share, & Industry Analysis Report: By Formulation, By Service (Preformulation and Formulation Development), By Therapeutic Area, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The formulation development outsourcing market encompasses the externalization of preclinical and clinical-stage formulation activities to specialized contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). These services support pharmaceutical and biopharmaceutical companies in optimizing the delivery, stability, and bioavailability of active pharmaceutical ingredients (APIs), particularly for complex and poorly soluble compounds. The market is witnessing sustained growth driven by increasing molecular complexity in drug pipelines, rising demand for specialized delivery systems, and the need for accelerated development timelines under cost constraints. Outsourcing has become essential for enabling access to advanced capabilities such as nanoformulation, sustained-release platforms, and solubility enhancement technologies, which are often cost-prohibitive to maintain in-house. A significant trend shaping the industry is the integration of formulation development into broader end-to-end service models that span from discovery to commercialization. Additionally, the deployment of predictive modeling, high-throughput screening, and data-driven formulation analytics is transforming how formulation decisions are made, reducing failure rates and cycle times.
Industry growth opportunities are expanding in the area of personalized medicine, where small-batch, highly tailored formulations require agile and technologically equipped outsourcing partners. Increasing regulatory scrutiny is pushing providers to adopt robust QbD and risk-based methodologies, further enhancing their strategic value. The growing emphasis on digitalization, modular service delivery, and real-time batch monitoring is expected to reshape client-provider relationships and redefine benchmarks for performance and compliance. The market's evolution is being driven by scientific innovation and the strategic need for operational flexibility in an increasingly complex therapeutic and regulatory landscape.
Formulation Development Outsourcing Market Report Highlights
By therapeutic area, in 2024, the oncology segment held the largest share due to the surge in demand for precision oncology therapeutics and the rapid pace of clinical pipeline expansion.
Based on end use, the government and academic institutes segment is expected to witness the highest CAGR during the forecast period due to their expanding role in translational research and early-stage drug discovery.
In 2024, Asia Pacific held the largest share due to a surge in regional biopharmaceutical innovation and rapidly expanding generics industry.
The North America formulation development outsourcing market is projected to register the highest CAGR during the forecast period, driven by an upsurge in biotech venture capital.
A few global key market players include Catalent Inc.; Charles River Laboratories International, Inc.; Element; Eurofins Scientific SE; Intertek Group plc; Labcorp; Lonza; Recipharm; SGS S.A.; and Thermo Fisher Scientific, Inc.
Polaris Market Research has segmented the market report on the basis of formulation, service, therapeutic area, end use, and region:
By Formulation Outlook (Revenue, USD Billion, 2020-2034)
Oral
Injectable
Topical
Others
By Service Outlook (Revenue, USD Billion, 2020-2034)
Preformulation
Formulation Development
By Therapeutic Area Outlook (Revenue, USD Billion, 2020-2034)
Oncology
Infectious Disease
Neurology
Hematology
Respiratory
Cardiovascular
Dermatology
Others
By End Use Outlook (Revenue, USD Billion, 2020-2034)
Pharmaceutical and Biopharmaceutical Companies
Government and Academic Institutes
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Formulation Development Outsourcing Market Insights
- 4.1. Formulation Development Outsourcing Market - Market Snapshot
- 4.2. Formulation Development Outsourcing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growth in Biopharmaceutical and Generic Drug Development
- 4.2.1.2. Advancements in Formulation Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Intellectual Property (IP) and Data Security Concerns
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Formulation Development Outsourcing Market Power Rating Trends
- 4.6. Value Chain Analysis
5. Formulation Development Outsourcing Market, by Formulation
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Formulation Development Outsourcing Market, by Formulation, 2020-2034 (USD Billion)
- 5.3. Oral
- 5.3.1. Formulation Development Outsourcing Market, by Oral, by Region, 2020-2034 (USD Billion)
- 5.4. Injectable
- 5.4.1. Formulation Development Outsourcing Market, by Injectable, by Region, 2020-2034 (USD Billion)
- 5.5. Topical
- 5.5.1. Formulation Development Outsourcing Market, by Topical, by Region, 2020-2034 (USD Billion)
- 5.6. Others
- 5.6.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)
6. Formulation Development Outsourcing Market, by Service
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 6.3. Preformulation
- 6.3.1. Formulation Development Outsourcing Market, by Preformulation, by Region, 2020-2034 (USD Billion)
- 6.4. Formulation Development
- 6.4.1. Formulation Development Outsourcing Market, by Formulation Development, by Region, 2020-2034 (USD Billion)
7. Formulation Development Outsourcing Market, by Therapeutic Area
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 7.3. Oncology
- 7.3.1. Formulation Development Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 7.4. Infectious Disease
- 7.4.1. Formulation Development Outsourcing Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
- 7.5. Neurology
- 7.5.1. Formulation Development Outsourcing Market, by Neurology, by Region, 2020-2034 (USD Billion)
- 7.6. Hematology
- 7.6.1. Formulation Development Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
- 7.7. Respiratory
- 7.7.1. Formulation Development Outsourcing Market, by Respiratory, by Region, 2020-2034 (USD Billion)
- 7.8. Cardiovascular
- 7.8.1. Formulation Development Outsourcing Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
- 7.9. Dermatology
- 7.9.1. Formulation Development Outsourcing Market, by Dermatology, by Region, 2020-2034 (USD Billion)
- 7.10. Others
- 7.10.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)
8. Formulation Development Outsourcing Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 8.3. Pharmaceutical and Biopharmaceutical Companies
- 8.3.1. Formulation Development Outsourcing Market, by Pharmaceutical and Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
- 8.4. Government and Academic Institutes
- 8.4.1. Formulation Development Outsourcing Market, by Government and Academic Institutes, by Region, 2020-2034 (USD Billion)
- 8.5. Others
- 8.5.1. Formulation Development Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)
9. Formulation Development Outsourcing Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Formulation Development Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Formulation Development Outsourcing Market - North America
- 9.3.1. North America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.3.2. North America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.3.3. North America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.4. North America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.3.5. Formulation Development Outsourcing Market - US
- 9.3.5.1. US: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.3.5.2. US: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.3.5.3. US: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.5.4. US: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.3.6. Formulation Development Outsourcing Market - Canada
- 9.3.6.1. Canada: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4. Formulation Development Outsourcing Market - Europe
- 9.4.1. Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.2. Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.3. Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.4. Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.5. Formulation Development Outsourcing Market - UK
- 9.4.5.1. UK: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.6. Formulation Development Outsourcing Market - France
- 9.4.6.1. France: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.6.2. France: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.6.3. France: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.6.4. France: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.7. Formulation Development Outsourcing Market - Germany
- 9.4.7.1. Germany: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.8. Formulation Development Outsourcing Market - Italy
- 9.4.8.1. Italy: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.9. Formulation Development Outsourcing Market - Spain
- 9.4.9.1. Spain: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.10. Formulation Development Outsourcing Market - Netherlands
- 9.4.10.1. Netherlands: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.11. Formulation Development Outsourcing Market - Russia
- 9.4.11.1. Russia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.12. Formulation Development Outsourcing Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5. Formulation Development Outsourcing Market - Asia Pacific
- 9.5.1. Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.5. Formulation Development Outsourcing Market - China
- 9.5.5.1. China: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.5.2. China: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.5.3. China: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.5.4. China: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.6. Formulation Development Outsourcing Market - India
- 9.5.6.1. India: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.6.2. India: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.6.3. India: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.6.4. India: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.7. Formulation Development Outsourcing Market - Malaysia
- 9.5.7.1. Malaysia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.8. Formulation Development Outsourcing Market - Japan
- 9.5.8.1. Japan: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.9. Formulation Development Outsourcing Market - Indonesia
- 9.5.9.1. Indonesia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.10. Formulation Development Outsourcing Market - South Korea
- 9.5.10.1. South Korea: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.11. Formulation Development Outsourcing Market - Australia
- 9.5.11.1. Australia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.12. Formulation Development Outsourcing Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6. Formulation Development Outsourcing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.5. Formulation Development Outsourcing Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.6. Formulation Development Outsourcing Market - UAE
- 9.6.6.1. UAE: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.7. Formulation Development Outsourcing Market - Israel
- 9.6.7.1. Israel: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.8. Formulation Development Outsourcing Market - South Africa
- 9.6.8.1. South Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.9. Formulation Development Outsourcing Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7. Formulation Development Outsourcing Market - Latin America
- 9.7.1. Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.5. Formulation Development Outsourcing Market - Mexico
- 9.7.5.1. Mexico: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.6. Formulation Development Outsourcing Market - Brazil
- 9.7.6.1. Brazil: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.7. Formulation Development Outsourcing Market - Argentina
- 9.7.7.1. Argentina: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.8. Formulation Development Outsourcing Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Formulation Development Outsourcing Market, By Formulation, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Formulation Development Outsourcing Market, By Service, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Formulation Development Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Formulation Development Outsourcing Market, by Therapeutic Area, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Catalent Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Charles River Laboratories International, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Element
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Eurofins Scientific SE
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Intertek Group plc
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Labcorp
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Lonza
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Recipharm
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. SGS S.A.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Thermo Fisher Scientific, Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
